KEYNOTEWEDa
Welcome & Opening Remarks
Speaker
Executive Director, CMC Regulatory Affairs, Gilead Sciences, Inc.
Related Products
Updates on ICH Quality Topics: ICH Q12, Q14 and M4Q
ICH delivers guidance on science- and risk-based strategies and is an enabler of greater harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner…
Concurrent Session: Path to a Global Quality Dossier - Part 2
Concurrent Session: Path to a Global Quality Dossier - Part 2|Industry has observed vastly different and region-specific CMC submission requirements and quality standards which can cause delays in approval of new medicines to patients worldwide…
